Provided by Tiger Trade Technology Pte. Ltd.

Takeda Pharmaceutical Co Ltd

16.25
-0.2300-1.40%
Post-market: 16.02-0.2275-1.40%19:58 EDT
Volume:4.01M
Turnover:64.96M
Market Cap:51.34B
PE:42.99
High:16.25
Open:16.13
Low:16.07
Close:16.48
52wk High:18.90
52wk Low:12.99
Shares:3.16B
Float Shares:3.06B
Volume Ratio:1.39
T/O Rate:0.13%
Dividend:0.63
Dividend Rate:3.87%
EPS(TTM):0.3780
EPS(LYR):0.3762
ROE:2.61%
ROA:2.63%
PB:1.05
PE(LYR):43.19

Loading ...

Protagonist Therapeutics Opts Out of Rusfertide US Profit-Sharing Arrangement With Takeda Pharmaceutical

MT Newswires Live
·
Apr 28

Takeda Targets Older Adults With New Dengue Vaccine Study, Eyeing Long-Term Market Upside

TIPRANKS
·
Apr 24

Takeda’s TAK-505 Trial Marks a New Bet on Difficult Solid Tumors

TIPRANKS
·
Apr 24

Takeda Extends Pediatric Entyvio Data: What Long-Term Safety Tracking Means for TAK Investors

TIPRANKS
·
Apr 17

Takeda upgraded to Outperform from Market Perform at Bernstein

TIPRANKS
·
Apr 08

Denali Therapeutics Regains Full Rights to Dementia Drug Following Takeda Partnership Termination

MT Newswires Live
·
Apr 06

Denali Therapeutics regains full rights to DNL593

TIPRANKS
·
Apr 06

Analysts Are Bullish on Top Healthcare Stocks: Allogene Therapeutics (ALLO), Takeda Pharmaceutical Company (TAK)

TIPRANKS
·
Mar 31

Alumis' Drug 'Very Positive' for Treatment of Psoriasis, Systemic Lupus Erythematosus, Oppenheimer Says

MT Newswires Live
·
Mar 30

Takeda says Phase 3 zasocitinib pill clears plaque psoriasis skin in about 70% patients

Reuters
·
Mar 30

Takeda announces new data from Phase 3 studies of TAK-279

TIPRANKS
·
Mar 29

Takeda proposes Julie Kim for board election; Christophe Weber retires as CEO on June 24, 2026 shareholder vote

Reuters
·
Mar 26

Takeda Pharmaceutical to Book 1500 Billion Yen Restructuring Charge for AI-Driven Efficiency Overhaul

Stock News
·
Mar 25

Takeda Pharmaceutical Approves Restructuring Plan; Expects $1.26 Billion Annual Savings

MT Newswires Live
·
Mar 25

Market Chatter: Takeda, Eli Lilly to Face Class Action Over Actos Cancer Risk

MT Newswires Live
·
Mar 23

Takeda’s EXPLORHAE HAE Study in Egypt: Real‑World Data With Long‑Term Investor Upside

TIPRANKS
·
Mar 14

These 8 drugs could help fight dementia - and they're already on the market

Dow Jones
·
Mar 07

Takeda’s TAK-861 Narcolepsy Study Moves Forward, Extending the Long-Term Bet on Sleep Disorders

TIPRANKS
·
Mar 06

Takeda Advances Fazirsiran Phase 3 Liver Study, Keeping Rare-Disease Growth Story in Play

TIPRANKS
·
Mar 06

Sector Update: Health Care Stocks Advance Late Afternoon

MT Newswires Live
·
Mar 05